StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for GT Biopharma

GT Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More GT Biopharma figures

See a number that looks wrong?